Apimeds Pharmaceuticals US (APUS) Shares Issued (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Shares Issued came in at $1.3 million in Q4 2025, up 513.21% YoY from $213692.0 in Q4 2024, and up 251.68% on a QoQ basis from $372604.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Shares Issued (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Shares Issued data on file, last reported at $1.3 million in Q4 2025.
- Quarterly Shares Issued rose 513.21% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 513.21% YoY) and the FY2025 annual result came in at $1.3 million, up 513.21% from the prior year.
- Shares Issued climbed to $1.3 million in Q4 2025, from $372604.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $1.3 million in Q4 2025 to a low of $213692.0 in Q4 2023.
- A 3-year average of $494592.6 and a median of $362604.0 in 2025 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued changed 0.0% — and 2025, when it jumped 513.21%.
- Tracing APUS's Shares Issued over 3 years: stood at $213692.0 in 2023, then changed by 0.0% to $213692.0 in 2024, then jumped by 513.21% to $1.3 million in 2025.
- The last three Shares Issued figures came in at $1.3 million (Q4 2025), $372604.0 (Q3 2025), and $362604.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.37 Mn | 7.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.31 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 372,604.00 |
| Sep 30, 2025 | 372,604.00 |
| Jun 30, 2025 | 362,604.00 |
| Jun 30, 2025 | 362,604.00 |
| Dec 31, 2024 | 213,692.00 |
| Dec 31, 2024 | 213,692.00 |
| Dec 31, 2023 | 213,692.00 |
| Dec 31, 2023 | 213,692.00 |